Cargando…
ALK, NUT, and TRK Do Not Play Relevant Roles in Gastric Cancer—Results of an Immunohistochemical Study in a Large Series
ALK, NUT, and TRK are rare molecular aberrations that are pathognomonic for specific rare tumors. In low frequencies, however, they are found in a wide range of other tumor entities. This study aimed to investigate the frequency, association with clinicopathological characteristics, and prognosis of...
Autores principales: | Glückstein, Marie-Isabelle, Dintner, Sebastian, Miller, Silvia, Vlasenko, Dmytro, Schenkirsch, Gerhard, Agaimy, Abbas, Märkl, Bruno, Grosser, Bianca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870766/ https://www.ncbi.nlm.nih.gov/pubmed/35204520 http://dx.doi.org/10.3390/diagnostics12020429 |
Ejemplares similares
-
Comprehensive Immunohistochemical Study of the SWI/SNF Complex Expression Status in Gastric Cancer Reveals an Adverse Prognosis of SWI/SNF Deficiency in Genomically Stable Gastric Carcinomas
por: Glückstein, Marie-Isabelle, et al.
Publicado: (2021) -
Ultrastaging Using Ex Vivo Sentinel Lymph Node Mapping and One-Step Nucleic Acid Amplification (OSNA) in Gastric Cancer: Experiences of a European Center
por: Märkl, Bruno, et al.
Publicado: (2021) -
Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes
por: Reitsam, Nic Gabriel, et al.
Publicado: (2022) -
Stroma AReactive Invasion Front Areas (SARIFA)—A New Easily to Determine Biomarker in Colon Cancer—Results of a Retrospective Study
por: Martin, Benedikt, et al.
Publicado: (2021) -
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma
por: Pacenta, Holly L, et al.
Publicado: (2018)